UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of: March 2024 (Report No. 3)
Commission File Number: 001-40753
ICECURE MEDICAL LTD.
(Translation of registrant’s name into English)
7 Ha’Eshel St., PO Box 3163
Caesarea, 3079504 Israel
(Address of principal executive office)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE TO
Tender Offer Statement Under Section 14(d)(1) or 13(e)(1)
of the Securities Exchange Act of 1934
PURETECH HEALTH PLC
(Name of Subject Company (Issuer) and Name of Filing Person (Offeror))
Ordinary Shares, par value £0.01 per share
(Title of Class of Securities)
G7297M101
(CUSIP Number of Class of Securities)
Daphne Zohar
Chief Executive Officer
PureTech Health plc
... (continue reading...)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2024
Commission File Number: 001-35729
JOYY Inc.
30 Pasir Panjang Road #15-31A Mapletree Business City,
Singapore 117440 (Address of principal executive offices)
Indicate by check mark whether the... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K R1 RCM Inc. /DE For: Mar 18
-
Form 8-K Cocrystal Pharma, Inc. For: Mar 19
-
Form 8-K ARCH RESOURCES, INC. For: Mar 19
-
Form 6-K PureTech Health plc For: Mar 19
-
Form 8-K KULR Technology Group, For: Mar 19
-
Form 4 FTC Solar, Inc. For: Mar 18 Filed by: Chatila Ahmad R
-
Form 6-K Maris Tech Ltd. For: Mar 19
-
Form 424B5 Athene Holding Ltd.
-
Form 10-K Coya Therapeutics, Inc. For: Dec 31
-
Form D/A CoastEdge Focus Fund
-
Form 8-K COLUMBUS MCKINNON CORP For: Mar 18
-
Form 4 CEVA INC For: Mar 15 Filed by: SILVER LOUIS
-
Form 8-K Coya Therapeutics, Inc. For: Mar 19
-
Form D SoraFinance a Series of
-
Form 6-K Evaxion Biotech A/S For: Mar 19
-
Form 424B5 UNITEDHEALTH GROUP INC
-
Form D OPX2024 AI 03 a Series
-
Form 4 Chubb Ltd For: Mar 15 Filed by: Wayland Joseph F
-
Form D Nesh a Series of CGF2021
-
Form 6-K dLocal Ltd For: Mar 19
-
Form 8-K MICROSTRATEGY Inc For: Mar 19
-
Form D Tundra Angels Upwardli
-
Form 10-K Aterian, Inc. For: Dec 31
-
Form ARS S&P Global Inc. For: Dec 31
-
Form 144 PARK OHIO HOLDINGS CORP Filed by: WERT JAMES W
-
Form 8-K Crescent Energy Co For: Mar 19
-
Form DEFA14A Floor & Decor Holdings,
-
Form SC 13D/A Bally's Corp Filed by: Standard General L.P.
-
Form 8-K Tonix Pharmaceuticals For: Mar 19
-
Form 8-K Acumen Pharmaceuticals, For: Mar 19
-
Form 8-K MICROSTRATEGY Inc For: Mar 18
-
Form DEFA14A S&P Global Inc.
-
Form 8-K CERUS CORP For: Mar 19
-
Form 3 Northwest Bancshares, For: Mar 18 Filed by: Schosser Douglas M
-
Form DEFA14A FIRST UNITED CORP/MD/
-
Form DEF 14A Floor & Decor Holdings, For: May 08
-
Form DEF 14A S&P Global Inc. For: May 01
-
Form RW Thimble Point Acquisitio
-
Form 8-K ORAMED PHARMACEUTICALS For: Mar 14
-
Form 4 Purple Innovation, Inc. For: Mar 15 Filed by: DeMartini Robert
-
Form 8-K DELCATH SYSTEMS, INC. For: Mar 18
-
Form 6-K Nano Labs Ltd For: Mar 19
-
Form 4 Purple Innovation, Inc. For: Mar 15 Filed by: HAYNOR ERIC SCOTT
-
Form PREC14A MRC GLOBAL INC. Filed by: ENGINE CAPITAL, L.P.
-
Form 4 Purple Innovation, Inc. For: Mar 15 Filed by: HUTCHINGS JEFFREY LAYNE
-
Form 8-K TC BioPharm (Holdings) For: Mar 14
-
Form 8-A12B LOBO EV TECHNOLOGIES
-
Form 4 Nuvectis Pharma, Inc. For: Mar 18 Filed by: BENTSUR RON
-
Form D Nfinite Nanotechnology
-
Form DEF 14A FIRST UNITED CORP/MD/ For: May 09